Alvogen, FDA Thursday, July 26, 2012 0.00 Neutral

FDA Approves OXYCODONE AND ACETAMINOPHEN — Alvogen, Inc.

Alvogen, Inc. received FDA approval on Thursday for a generic version of Oxycodone and Acetaminophen tablets, enabling the company to enter the established market for this widely prescribed pain medication.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day